Cytek Biosciences (CTKB) Retained Earnings (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Retained Earnings data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 489.0% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 489.0% YoY), and the FY2025 full-year result was $2.2 million, up 106.37% from the prior year.
• Retained Earnings for Q1 2026 stood at $2.4 million, up from $2.2 million in the prior quarter.
• Across five years, Retained Earnings topped out at $2.4 million in Q1 2026 and bottomed at -$35.2 million in Q4 2024.
• The 5-year median for Retained Earnings is -$1.6 million (2024), against an average of -$12.3 million.
• The widest annual swing landed in 2023, when Retained Earnings plunged 6443.58%; it then jumped 712.87% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$17.0 million in 2022, then tumbled by 71.33% to -$29.2 million in 2023, then slipped by 20.64% to -$35.2 million in 2024, then jumped by 106.37% to $2.2 million in 2025, then grew by 5.71% to $2.4 million in 2026.
• The last three Retained Earnings figures came in at $2.4 million (Q1 2026), $2.2 million (Q4 2025), and $821000.0 (Q3 2025), per Business Quant data.

Peer Comparison